Company intelligence / Profile preview

Lillycover

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Lillycover develops AI-powered diagnostic devices and platforms that analyze users' skin conditions using sensors and machine learning. Their solutions provide real-time assessments of parameters such as hydration, oiliness, elasticity, pH balance, and recommend personalized skincare routines. The company has demonstrated strong commercial traction in Asia with ongoing international expansion. Clinical validation data may be limited but user adoption suggests practical utility.

Therapeutic areas: Dermatology
Modalities: DeviceDiagnostic deviceDigital health platform
Industry: Physiological Monitoring

Partnerships

Amorepacific Group (Korea)various beauty clinics/distributors in Asia/EU/US markets

Beyond the preview

Go deeper on Lillycover.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lillycover.

Explore the full profile